AI adoption
Also, See-Mode has received the first US FDA approval for a thyroid ultrasound analysis AI solution.
Abbott has received clearance from the FDA for its imaging software that uses artificial intelligence to provide doctors a better view of blood flow and blockages in heart vessels.
The solution answers common questions about COVID-19 in Welsh or English.
AI is steadily proving itself to the clinical community, but there are some aspects of care in which an algorithm will never be granted full control, said Cardiologs CEO Yann Fleureau.